Effect of High Fat High Protein Meal in Type 1 Diabetes
NCT07158385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2025-09-05
Summary
Aim: Despite optimal glycemic control in individuals with type 1 diabetes, post-meal hyperglycemia remains a clinical challenge, and it has been identified as an independent risk factor for the development of long-term complications, including cardiovascular diseases. With the increasing use of continuous glucose monitoring systems, evidence has been obtained that traditional insulin dosing strategies are not sufficiently effective as the effects of meals with different macronutrient content on glycemic response are further illuminated. It is argued that relying solely on counting carbohydrates for achieving glycemic control is insufficient, and that proteins and fats can cause an increase in postprandial glycemic response. Therefore, it is necessary for Type 1 diabetics to determine insulin dosage based not only on carbohydrates, but also on the amount of fats and proteins in their meals. This study investigated the protein and fat counting in addition to carbohydrate counting on the postprandial blood glucose levels in adolescents with Type 1 diabetes and analyzed the effect of the dietary fat and protein on glucagon, glucagon-like peptide-1 (GLP-1) and free fatty acid (FFA) levels.
Methods: In this single center, randomised controlled, single-blind study with regards to insulin, 11 adolescents aged 12-18 years using continuous subcutaneous insulin infusion (CSII) were given standard meal (SM), and three test meals (HFHP: high-fat-high-protein meal using carbohydrate counting; HFHP-a: high-fat-high-protein meal using carbohydrate and fat counting; HFHP-b: high-fat-high-protein meal using carbohydrate and fat-protein counting) to compare postprandial 6 hours glucose response using continuous glucose monitoring system (CGMS). Also postprandial plasma glucagon, FFA, and GLP-1 levels were compared for 6 hours after a standard meal and a high-fat-high-protein meal.
Conditions
- Type 1 Diabetes Mellitus
- Adolescent
Interventions
- OTHER
-
Standard test meal (SM)
Participants were given a standard breakfast meal with a fat and protein content similar to their daily intake. Insulin was administered according to their individual carbohydrate-to-insulin ratio. On the test day, venous blood samples were collected from the catheter inserted for GLP-1, glucagon, and free fatty acid analysis immediately before the meal (t=0 minute) and at 30, 60, 90, 120, 240, and 360 minutes after the meal.
- OTHER
-
High fat high protein meal-carbohydrate counting (HFHP)
On the high-fat, high-protein meal-carbohydrate counting test day (HFHP), participants were given a high-fat and high-protein breakfast. Insulin was administered according to the individual carbohydrate-to-insulin ratio. On the test day, venous blood samples were collected from the catheter inserted for GLP-1, glucagon, and free fatty acid analysis immediately before the meal (t=0 minute) and at 30, 60, 90, 120, 240, and 360 minutes after the meal.
- OTHER
-
High fat high protein meal-fat counting (HFHP-a)
On the high-fat, high-protein meal-fat-counting test day (HFHP-a), participants were given a high-fat and protein breakfast. In addition to their individual carbohydrate/insulin ratio, insulin was administered based on fat counting (1 unit for every 15 g of fat after the first 15 g of fat in the meal). In this method, the insulin dose calculated based on their individual carbohydrate/insulin ratio was delivered via insulin pump as a standard bolus, while the insulin dose calculated based on their fat count was delivered as a 4 hour extended bolus.
- OTHER
-
High fat high protein meal-fat and protein counting (HFHP-b)
On the high-fat, high-protein meal-fat and protein counting test day (HFHP-b), participants were given a high-fat and protein breakfast. In addition to the individual carbohydrate/insulin ratio, insulin was administered according to the adapted Pankowska Algorithm (1 FPU for every 100 kcal after the first 200 kcal of the meal). In this method, the insulin dose calculated based on the individual carbohydrate/insulin ratio was delivered as a standard bolus by an insulin pump, while the insulin dose calculated based on the fat and protein count was delivered as a spread over 4 hours.
Sponsors & Collaborators
-
Hacettepe University Scientific Research Projects Coordination Unit
collaborator UNKNOWN -
Cumhuriyet University
lead OTHER
Principal Investigators
-
Zeynep Alev Özön, MD, Prof. · Hacettepe University
-
Hülya Gökmen Özel, Prof. Dr. · Hacettepe University
-
Elmas Nazlı Gönç, MD, Prof. · Hacettepe University
-
Ayfer Alikaşifoğlu, MD, Prof. · Hacettepe University
-
Oytun Portakal, Assoc. Prof. Dr. · Hacettepe University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2019-10-30
- Completion
- 2021-02-17
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus
NCT02882737 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy Adults
NCT04730882 ·Status: COMPLETED
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
NCT01461616 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
NCT07319286 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet
NCT03710928 ·Status: RECRUITING ·Phase: NA
-
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182 ·Status: RECRUITING ·Phase: PHASE3
-
Intermittent Fasting in Adults With Type 1 Diabetes
NCT06134986 ·Status: COMPLETED ·Phase: NA
-
The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
NCT03081676 ·Status: COMPLETED ·Phase: NA
-
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
NCT03582956 ·Status: TERMINATED ·Phase: NA
-
Carbohydrates Under Target for Type 1 Diabetes Management
NCT04758858 ·Status: WITHDRAWN ·Phase: NA
-
Liraglutide in Adolescents With Type 1 Diabetes
NCT02516657 ·Status: COMPLETED ·Phase: PHASE3
-
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
NCT05330247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Glucagon Efficiency After High and Low Carbohydrate Diet
NCT02578498 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus
NCT00603031 ·Status: COMPLETED ·Phase: NA
-
Fats And Carbohydrates Quality on Postprandial glycemIc Response in Type 1 Diabetes
NCT02330939 ·Status: UNKNOWN ·Phase: NA
-
Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
NCT04079881 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes
NCT07278063 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
NCT00716170 ·Status: COMPLETED
-
Effect of GIP After a Meal in Patients With Type 2 Diabetes
NCT03702660 ·Status: COMPLETED ·Phase: NA
-
"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
NCT00881543 ·Status: COMPLETED ·Phase: NA
-
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
NCT06934707 ·Status: NOT_YET_RECRUITING ·Phase: NA